JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

Clinical trial NCT05002270 · COMPLETED

Trial details

NCT number: NCT05002270
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor NSCLC CRC

Start date: 2021-09-03
Primary completion: 2025-02-12
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.